FOND TELETHON innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	WIPO (World Intellectual Property Organization)	30
#2	EPO (European Patent Office)	27
#3	Australia	23
#4	United States	19
#5	Italy	17
#6	Canada	16
#7	China	10
#8	Brazil	7
#9	Israel	6
#10	Republic of Korea	4
#11	Mexico	2
#12	New Zealand	2
#13	EAPO (Eurasian Patent Organization)	1
#14	United Kingdom	1
#15	Japan	1

#	Technology
#1	Medical preparations
#2	Therapeutic chemical compounds
#3	Microorganisms
#4	Peptides
#5	Sugars
#6	Analysing materials
#7	Enzymes
#8	Measuring microorganism processes
#9	Animal care
#10	Heterocyclic compounds

Publication	Filing date	Title
WO2020104558A1	2019-11-20	Heterocyclic compounds and medical use thereof
WO2020079033A1	2019-10-15	Genome editing methods and constructs
WO2020079034A2	2019-10-15	Intein proteins and uses thereof
WO2020070333A1	2019-10-07	Ezrin inhibitors and uses thereof
AU2019291069A1	2019-06-19	Production of engineered dendritic cells and uses thereof
WO2019207167A1	2019-04-29	Therapy of sulfatase deficiencies
WO2019202162A1	2019-04-23	Mir-181 inhibitors and uses thereof
WO2019122425A1	2018-12-21	Ectopically expressed transcription factors and uses thereof
AU2018253959A1	2018-04-20	Gene therapy
GB201801511D0	2018-01-30	Gene therapy
EP3509628A1	2017-09-11	Combined therapy for mucopolysaccharidosis type vi (maroteaux-lamy-syndrome)
AU2017266468A1	2017-05-19	Gene therapy
EP3414262A1	2017-02-09	Synthetic promoters and uses thereof
WO2017137493A1	2017-02-09	Synthetic promoters and uses thereof
CN108431033A	2016-09-28	The treatment of bone uptake illness
US2018050092A1	2016-03-11	Il-10-producing cd4+ t cells and uses thereof
JP2016116533A	2016-03-09	Therapeutic strategy for treating cns lesion in mucopolysaccharidosis
MX2017011255A	2016-03-03	Multiple vector system and uses thereof.
CA2930282A1	2014-11-20	Artificial dna-binding proteins and uses thereof
AU2014295000A1	2014-07-25	Inhibitors of FAPP2 and uses thereof